KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $644.8 million.

  • Ginkgo Bioworks Holdings' Total Non-Current Liabilities fell 7.97% to $612.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $612.2 million, marking a year-over-year decrease of 7.97%. This contributed to the annual value of $644.8 million for FY2024, which is 18.59% up from last year.
  • As of FY2024, Ginkgo Bioworks Holdings' Total Non-Current Liabilities stood at $644.8 million, which was up 18.59% from $543.8 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Total Non-Current Liabilities registered a high of $771.9 million during FY2022, and its lowest value of $202.1 million during FY2020.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $644.8 million (2024), whereas its average is $653.5 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Total Non-Current Liabilities surged by 109.87% in 2022, and later fell by 29.55% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Total Non-Current Liabilities stood at $202.1 million in 2020, then soared by 82.00% to $367.8 million in 2021, then soared by 109.87% to $771.9 million in 2022, then decreased by 29.55% to $543.8 million in 2023, then grew by 18.59% to $644.8 million in 2024.